ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 117 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $231,000 | -18.7% | 158,091 | -21.0% | 0.00% | -33.3% |
| Q4 2016 | $284,000 | -8.7% | 200,131 | +12.7% | 0.00% | -25.0% |
| Q3 2016 | $311,000 | -13.9% | 177,628 | -15.8% | 0.00% | -20.0% |
| Q2 2016 | $361,000 | -12.6% | 210,915 | +0.7% | 0.01% | -16.7% |
| Q1 2016 | $413,000 | -5.7% | 209,394 | -9.1% | 0.01% | +20.0% |
| Q4 2015 | $438,000 | +10.3% | 230,291 | +10.8% | 0.01% | -16.7% |
| Q3 2015 | $397,000 | -61.8% | 207,848 | -7.2% | 0.01% | -57.1% |
| Q2 2015 | $1,039,000 | -1.4% | 223,936 | -7.1% | 0.01% | +16.7% |
| Q1 2015 | $1,054,000 | +57.3% | 241,167 | +25.0% | 0.01% | +50.0% |
| Q4 2014 | $670,000 | -20.2% | 192,943 | -3.8% | 0.01% | -27.3% |
| Q3 2014 | $840,000 | -42.4% | 200,527 | -19.4% | 0.01% | -42.1% |
| Q2 2014 | $1,458,000 | -41.5% | 248,861 | -37.1% | 0.02% | -38.7% |
| Q1 2014 | $2,494,000 | +257.8% | 395,858 | +232.2% | 0.03% | +210.0% |
| Q4 2013 | $697,000 | -39.9% | 119,156 | -45.8% | 0.01% | -64.3% |
| Q3 2013 | $1,160,000 | -19.7% | 220,026 | +17.2% | 0.03% | 0.0% |
| Q2 2013 | $1,445,000 | – | 187,686 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 10,500,000 | $17,955,000 | 0.87% |
| SENZAR ASSET MANAGEMENT, LLC | 1,872,191 | $3,201,447,000 | 0.70% |
| Virtus ETF Advisers LLC | 277,607 | $475,000 | 0.35% |
| GLOBEFLEX CAPITAL L P | 571,500 | $977,000 | 0.27% |
| Lyons Wealth Management, LLC. | 42,408 | $73,000 | 0.11% |
| TFS CAPITAL LLC | 222,736 | $381,000 | 0.07% |
| Jacobi Capital Management LLC | 35,000 | $56,000 | 0.03% |
| Renaissance Technologies | 5,601,355 | $9,578,000 | 0.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 26,725,936 | $45,701,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 46,300 | $79,000 | 0.01% |